The Diagnostics & Lab Testing Business Brief — Wednesday, November 11, 2026
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
By:
Summary
The Diagnostics & Lab Testing Business Brief — Wednesday, November 11, 2026
- Waters receives FDA 510(k) clearance for the BD OneFlow™ LST and BD OneFlow™ B-CLPD T1 ready-to-use flow cytometry tests for identifying B-cell non-Hodgkin lymphoma, including CLL (96.3% sensitivity / 98.2% specificity for CLL); U.S. commercial availability planned for spring 2027. (PR Newswire)
- bioMérieux receives FDA 510(k) clearance and EU IVDR CE marking for VITEK® PRO, its automated microbial identification and antimicrobial susceptibility testing system for medium- and high-volume labs; it will replace VITEK 2 and VITEK XL, with commercial launch beginning Q1 2027. (Clinical Lab Products)
- Mercy BioAnalytics is selected to participate in STRIDE-RCT, the NHS multicancer blood test trial led by the University of Birmingham, expected to involve more than 20,000 patients across at least 200 GP practices in England. (PR Newswire)
- UW Medicine becomes the first U.S. academic laboratory to bring Roche Diagnostics' cobas® Mass Spec solution into clinical use, beginning patient testing on November 2, 2026 with vitamin and hormone testing. (UW Medicine Newsroom)
- FDA finalizes guidance on validating in vitro diagnostic tests for emerging pathogens during a declared public health emergency, setting expectations for EUA submissions for lab, point-of-care, and home tests. (Clinical Lab Products)
- Biozen presents BP2000 data at AHA Scientific Sessions 2026: the next generation of its FDA-cleared BP1000 fingertip system cut average measurement time by 40% in a prospective 85-participant study; BP2000 is investigational. (PR Newswire)
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.